| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 14.16 Billion | USD 75.74 Billion | 18.26% | 2024 |
FrequentlyAsked Questions
Synthetic biology is a field that combines biology, engineering, genetics, chemistry, and computational sciences to design and build new biological parts, devices, and systems or to redesign existing natural biological systems, enabling the creation of novel biological functions not found in nature.
The synthetic biology market is expected to be driven by falling DNA synthesis and sequencing costs, rising demand for biopharmaceuticals and precision medicine, increasing investment in sustainable bio-manufacturing, and growing integration of digital technologies with biological design processes.
According to market research, the global synthetic biology market was valued at approximately USD 14.16 billion in 2024 and is projected to reach around USD 75.74 billion by 2034, driven by expanding applications across healthcare, industrial manufacturing, and agriculture.
The synthetic biology market is expected to grow at a compound annual growth rate (CAGR) of approximately 18.26% from 2025 to 2034, fueled by technological advances, increasing investment, and expanding application areas.
North America dominates the global synthetic biology market due to substantial research funding, strong academic-industry collaborations, and a vibrant biotech startup ecosystem. At the same time, Asia-Pacific represents the fastest-growing regional market.
Key players in the synthetic biology market include Thermo Fisher Scientific Inc., Merck KGaA (MilliporeSigma), Agilent Technologies, Inc., Novozymes A/S, Ginkgo Bioworks, Amyris, Inc., Twist Bioscience Corporation, Genscript Biotech Corporation, Codexis, Inc., Synthetic Genomics, Inc., New England Biolabs, Inc., Eurofins Scientific, Integrated DNA Technologies, Inc. (Danaher Corporation), Arzeda Corp., and ATUM.
The report provides a comprehensive analysis of the synthetic biology market, including an in-depth discussion of market drivers, restraints, technological trends, regulatory landscapes, and future growth opportunities. The report also explores competitive dynamics, regional markets, and ongoing innovations in sustainable bio-manufacturing technologies.
HappyClients